Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain

Sarah M. Sweitzer(Dartmouth College), David E. Martin(Amgen (United States)), Joyce A. DeLeo(Dartmouth College)

Neuroscience

March 1, 2001

10.1016/s0306-4522(00)00574-1

Cited by 344

Abstract

Related Papers

Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function

Gennadij Raivich, Marion Bohatschek, Christian U.A. Kloss et al.|Brain Research Reviews|1999|832

Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor <i>α</i>

Clifford J. Woolf, Andrew Allchorne, Bared Safieh‐Garabedian et al.|British Journal of Pharmacology|1997|669

Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states

Linda R. Watkins, Steven F. Maier, Lisa E. Goehler|Pain|1995|657

Kappa–opioids produce significantly greater analgesia in women than in men

Robert W. Gear, Christine Miaskowski, Newton C. Gordon et al.|Nature Medicine|1996|456

The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat

Stephen T. Meller, C. Dykstra, D. Grzybycki et al.|Neuropharmacology|1994|333